These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8179860)

  • 21. Performance of immuno-positron emission tomography with zirconium-89-labeled chimeric monoclonal antibody U36 in the detection of lymph node metastases in head and neck cancer patients.
    Börjesson PK; Jauw YW; Boellaard R; de Bree R; Comans EF; Roos JC; Castelijns JA; Vosjan MJ; Kummer JA; Leemans CR; Lammertsma AA; van Dongen GA
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2133-40. PubMed ID: 16609026
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selection of monoclonal antibody E48 IgG or U36 IgG for adjuvant radioimmunotherapy in head and neck cancer patients.
    de Bree R; Roos JC; Plaizier MA; Quak JJ; van Kamp GJ; den Hollander W; Snow GB; van Dongen GA
    Br J Cancer; 1997; 75(7):1049-60. PubMed ID: 9083342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Perspectives of combined radioimmunotherapy and anti-EGFR antibody therapy for the treatment of residual head and neck cancer.
    van Gog FB; Brakenhoff RH; Stigter-van Walsum M; Snow GB; van Dongen GA
    Int J Cancer; 1998 Jul; 77(1):13-8. PubMed ID: 9639387
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The feasibility of radioimmunotherapy of head and neck cancer.
    Gerretsen M; Quak JJ; Brakenhoff RH; Snow GB; van Dongen GA
    Eur J Cancer B Oral Oncol; 1994; 30B(2):82-7. PubMed ID: 8032305
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High dose rhenium-186-labeling of monoclonal antibodies for clinical application: pitfalls and solutions.
    van Gog FB; Visser GW; Stroomer JW; Roos JC; Snow GB; van Dongen GA
    Cancer; 1997 Dec; 80(12 Suppl):2360-70. PubMed ID: 9406684
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of a coincidence gamma camera to detect primary tumor with 18fluoro-2-deoxy-glucose in cervical lymph node metastases from an unknown origin.
    Périé S; Talbot JN; Monceaux G; Grahek D; Kerrou K; Montravers F; St Guily JL
    Ann Otol Rhinol Laryngol; 2000 Aug; 109(8 Pt 1):755-60. PubMed ID: 10961809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radioimmunotherapy in patients with head and neck squamous cell carcinoma: initial experience.
    Colnot DR; Quak JJ; Roos JC; de Bree R; Wilhelm AJ; Snow GB; van Dongen GA
    Head Neck; 2001 Jul; 23(7):559-65. PubMed ID: 11400244
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Immunoscintigraphy of carcinomas in the area of the head-neck with technetium-99m marked monoclonal antibody 174H.64. A new diagnostic procedure].
    Kiefer J; Baum RP; Knecht R; Hertel A; Niesen A; von Ilberg C; Hör G
    HNO; 1994 Sep; 42(9):546-52. PubMed ID: 7989226
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of MET oncogene/hepatocyte growth factor receptor in lymph node metastases from head and neck squamous cell carcinomas.
    Galeazzi E; Olivero M; Gervasio FC; De Stefani A; Valente G; Comoglio PM; Di Renzo MF; Cortesina G
    Eur Arch Otorhinolaryngol; 1997; 254 Suppl 1():S138-43. PubMed ID: 9065649
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Bilateral lymph node metastases in the neck from uncertain primary in the nasal vestibulum].
    Olszewski J; Miloński J
    Otolaryngol Pol; 2007; 61(6):1011-3. PubMed ID: 18546954
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhanced control by radiotherapy of cervical lymph node metastases arising from nasopharyngeal carcinoma compared with nodal metastases from other head and neck squamous cell carcinomas.
    Chow E; Payne D; Keane T; Panzarella T; Izard MA
    Int J Radiat Oncol Biol Phys; 1997 Aug; 39(1):149-54. PubMed ID: 9300749
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Analyses of clinicopathologic factors affecting neck control after postoperative radiation as adjuvant treatment for lymph node metastasis in head and neck squamous cell carcinoma].
    Di B; Li XM; Zhang JJ; Liu S; Song Q; Tao ZF; Fan C
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Jul; 51(7):485-90. PubMed ID: 27480295
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radioimmunodetection of head and neck cancer. A review.
    Hopsu EV; Kairemo KJ
    Acta Oncol; 1993; 32(7-8):735-40. PubMed ID: 8305220
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distant lymphatic metastasis from head and neck cancer.
    Alavi S; Namazie A; Sercarz JA; Wang MB; Blackwell KE
    Ann Otol Rhinol Laryngol; 1999 Sep; 108(9):860-3. PubMed ID: 10527276
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Computed tomography of cervical lymph node metastases in malignant tumors of the head and neck region].
    Bähren W; Haase S; Lenz M; Ranzinger G; Wierschin W
    Rofo; 1983 Sep; 139(3):281-4. PubMed ID: 6411547
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of cervical lymph node metastases in squamous cell carcinoma of the head and neck.
    Don DM; Anzai Y; Lufkin RB; Fu YS; Calcaterra TC
    Laryngoscope; 1995 Jul; 105(7 Pt 1):669-74. PubMed ID: 7603268
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Head and neck cancer localization with indium labelled carcinoembryonic antigen: a pilot project.
    Timon CI; McShane D; Hamilton D; Walsh MA
    J Otolaryngol; 1991 Aug; 20(4):283-7. PubMed ID: 1920585
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase I therapy study of 186Re-labeled chimeric monoclonal antibody U36 in patients with squamous cell carcinoma of the head and neck.
    Colnot DR; Quak JJ; Roos JC; van Lingen A; Wilhelm AJ; van Kamp GJ; Huijgens PC; Snow GB; van Dongen GA
    J Nucl Med; 2000 Dec; 41(12):1999-2010. PubMed ID: 11138685
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The efficacy of FDG-PET in head-and-neck cancer with neck metastasis after definitive radiation treatment: in regard to Yao et al. (Int J Radiat Oncol Biol Phys 2005;63:991-999).
    Wang TF; Tsai EL; Kao RH
    Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):633; author reply 633-4. PubMed ID: 16690448
    [No Abstract]   [Full Text] [Related]  

  • 40. Cystic metastasis from head and neck squamous cell cancer: a distinct disease variant?
    Goldenberg D; Sciubba J; Koch WM
    Head Neck; 2006 Jul; 28(7):633-8. PubMed ID: 16477605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.